-
Moderna Inc. (MRNA $34.67)
- $34.67 Cap: $13.40B
- View MRNA Profile
- View Questions on MRNA
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Abbott Laboratories (ABT $125.83)
- $125.83 P/E (TTM): 16.33X Cap: $218.92B
- View ABT Profile
- View Questions on ABT
-
Eli Lilly and Company (LLY $798.89)
- $798.89 P/E (TTM): 63.18X Cap: $757.13B
- View LLY Profile
- View Questions on LLY
-
Pfizer Inc. (PFE $25.36)
- $25.36 P/E (TTM): 18.22X Cap: $144.18B
- View PFE Profile
- View Questions on PFE
-
Novo Nordisk A/S (NVO $70.03)
- $70.03 P/E (TTM): 18.84X Cap: $363.68B
- View NVO Profile
- View Questions on NVO
-
Moderna Inc. (MRNA $34.67)
- $34.67 Cap: $13.40B
- View MRNA Profile
- View Questions on MRNA
Q: Hello,
Given the current price levels of both MRNA and PFE would this be a good time to take position in either one of those? If so which one would you recommend.
Thank you!
Given the current price levels of both MRNA and PFE would this be a good time to take position in either one of those? If so which one would you recommend.
Thank you!
-
Moderna Inc. (MRNA $34.67)
- $34.67 Cap: $13.40B
- View MRNA Profile
- View Questions on MRNA
Q: Hi, Could you please provide your opinion on MRNA current price/valuation/potential growth ? The stock is currently down -37% YTD. At this price, do you see a potential contrarian long term investment ? thank you
-
Booking Holdings Inc. (BKNG $5,736.32)
- $5,736.32 P/E (TTM): 36.01X Cap: $186.66B
- View BKNG Profile
- View Questions on BKNG
-
Ulta Beauty Inc. (ULTA $508.10)
- $508.10 P/E (TTM): 19.66X Cap: $22.83B
- View ULTA Profile
- View Questions on ULTA
-
ResMed Inc. (RMD $273.37)
- $273.37 P/E (TTM): 30.04X Cap: $40.09B
- View RMD Profile
- View Questions on RMD
-
e.l.f. Beauty Inc. (ELF $117.66)
- $117.66 P/E (TTM): 60.13X Cap: $6.24B
- View ELF Profile
- View Questions on ELF
-
Moderna Inc. (MRNA $34.67)
- $34.67 Cap: $13.40B
- View MRNA Profile
- View Questions on MRNA
-
Celsius Holdings Inc. (CELH $45.16)
- $45.16 P/E (TTM): 134.36X Cap: $11.42B
- View CELH Profile
- View Questions on CELH
-
Snowflake Inc. (SNOW $212.56)
- $212.56 Cap: $70.93B
- View SNOW Profile
- View Questions on SNOW
-
Rivian Automotive Inc. (RIVN $14.02)
- $14.02 Cap: $16.07B
- View RIVN Profile
- View Questions on RIVN
Q: I'm a long term growth investor. Planning to do a little tax loss selling. I'm down on these 5 names. What do you think of each name from an investment point of view, in what order would you sell, and what, in your view, could be a possible replacement name for each. Thanks.
Insiders
Share Information
SEC Filings
News and Media